Background Different studies have proved in recent years that hypofractionated radiotherapy
(RT) improves overall survival of patients affected by locally advanced, unresectable …

Purpose Although surgery is the standard of care for resectable pancreatic cancer (PC),
standard-dose chemoradiation therapy and chemotherapy alone are suitable for patients …

Objectives: Ablative therapies have been increasingly utilized in the treatment of locally
advanced pancreatic cancer (LAPC). Irreversible electroporation (IRE) is an energy delivery …

Recent years have seen both a fresh knowledge of cancer and impressive advancements in
its treatment. However, the clinical treatment paradigm of cancer is still difficult to implement …

Despite of the predominant role of chemotherapy and surgery in pancreatic ductal
adenocarcinoma (PDAC), radiotherapy (RT) still has a place in multimodal management of …

Background Even when resectable pancreatic cancer (PC) is associated with a dismal
prognosis. Initial presentation varies according with primary tumor location. Aim of this …

Purpose Pancreatic stereotactic body radiation therapy (SBRT) is limited to gross tumor
without elective coverage for subclinical disease. Given a better understanding of …

Combining the latest targeted biologic agents with the most advanced radiation
technologies has been an exciting development in the treatment of cancer patients …

Advances in image-guided radiotherapy have brought about improved oncologic outcomes
and reduced toxicity. The next generation of image guidance in the form of magnetic …

Pancreatic ductal adenocarcinoma (PDAC) is one of the major causes of death in the
Western world, and it is estimated to become the second leading cause of tumour-related …